tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cantargia AB to Release H1 2025 Interim Report with Investor Presentation
PremiumCompany AnnouncementsCantargia AB to Release H1 2025 Interim Report with Investor Presentation
2M ago
Cantargia Reports Preliminary Phase 2 Results for Nadunolimab in TNBC
Premium
Company Announcements
Cantargia Reports Preliminary Phase 2 Results for Nadunolimab in TNBC
3M ago
Cantargia’s Nadunolimab Shows Promise in Advanced Lung Cancer Trial
Premium
Company Announcements
Cantargia’s Nadunolimab Shows Promise in Advanced Lung Cancer Trial
3M ago
Cantargia AB Announces Key Resolutions from Annual General Meeting
PremiumCompany AnnouncementsCantargia AB Announces Key Resolutions from Annual General Meeting
5M ago
Cantargia AB’s Promising Interim Report for Early 2025
Premium
Company Announcements
Cantargia AB’s Promising Interim Report for Early 2025
5M ago
Cantargia’s CAN10 Achieves Promising Phase 1 Results, Sets Stage for Phase 2
Premium
Company Announcements
Cantargia’s CAN10 Achieves Promising Phase 1 Results, Sets Stage for Phase 2
5M ago
Cantargia’s Nadunolimab Shows Promise in Counteracting Tumor-Induced Immune Suppression
PremiumCompany AnnouncementsCantargia’s Nadunolimab Shows Promise in Counteracting Tumor-Induced Immune Suppression
5M ago
Cantargia’s Nadunolimab Shows Promise in Counteracting Tumor-Induced Immunosuppression
Premium
Company Announcements
Cantargia’s Nadunolimab Shows Promise in Counteracting Tumor-Induced Immunosuppression
5M ago
Cantargia’s Nadunolimab Shows Promise in Overcoming Cancer Immunosuppression
Premium
Company Announcements
Cantargia’s Nadunolimab Shows Promise in Overcoming Cancer Immunosuppression
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100